
Matthew L Anderson MD PhD
Gynecologic Oncology
Professor, Gynecologic Oncology and Molecular Pharmacology & Physiology University of South Florida Morsani College of Medicine Associate Director for Shared Resources, Tampa General Hospital Cancer Institute
Join to View Full Profile
2 Tampa General CircleSuite 6005 STCTampa, FL 33606
Phone+1 813-259-8512
Fax+1 813-259-8593
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2002
- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
- Yale School of MedicineClass of 1995
Certifications & Licensure
- FL State Medical License 2018 - 2027
- TX State Medical License 2000 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23
- Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers Start of enrollment: 2019 Feb 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Evaluating the Role of Hyperthermic Intraperitoneal Chemotherapy in Cytoreductive Surgery for Advanced-Stage Ovarian Cancer.Adrian Kohut, Matthew L Anderson, Vaagn Andikyan, Maya Yasukawa, Lindsey Nguy
Annals of Surgical Oncology. 2025-04-06 - 1 citationsAssessment of the Histone Mark-based Epigenomic Landscape in Human Myometrium at Term Pregnancy.San-Pin Wu, Elvis Quiroz, Tianyuan Wang, Skylar Montague Redecke, Xin Xu
Biorxiv. 2025-02-26 - Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis.Ayesha B Alvero, Sharon Wu, Alex Farrell, Seongho Kim, John J Wallbillich
Gynecologic Oncology. 2025-02-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: